Top 5 Takeaways as HHS Addresses Misconceptions on the Applicability of HIPAA to COVID-19 Vaccination Information
2 March 2022
Foley Partner Jennifer Urban, a member of the firm’s Innovative Technology sector, as well as the Cybersecurity and Privacy, Security & Information Management practices, will present the “Top 5 Takeaways as HHS Addresses Misconceptions on the Applicability of HIPAA to COVID-19 Vaccination Information” at the Thirty-First Annual National HIPAA Summit on Wednesday, March 2, 2022.
Jennifer will provide a brief refresher about who HIPAA regulates and what information it covers, and then dispel five common misconceptions about HIPAA’s applicability to COVID-19 vaccine information. Topics discussed include where HIPAA stands on:
- Asking someone about their vaccination status
- Preventing individuals from disclosing their vaccination status
- Vaccination information stored in employee files
- Covered entity authorization to disclose vaccination information
- Covered entity authorization to disclose COVID-19 testing results
For more information and to register, please visit the National HIPAA Summit website.
People
Related Insights
19 November 2024
Events
Privacy Law Issues Confronting the Cannabis and Hemp Economy
Foley Partner Aaron Tantleff joins the faculty for a California Lawyers Association (CLA) webinar aimed at providing California lawyers with an introduction to privacy law concepts and issues that intersect with commercial cannabis and hemp.
13 November 2024
Events
Florida Institute of CFOs (fiCFO) 2024 Summit
Foley Partner Aaron Tantleff is a featured speaker at the Florida Institute of CFOs (fiCFO) 2024 Summit taking place near Orlando on November 12-14, 2024, which Foley is proud to support as a Platinum Sponsor.
14 November 2024
Events
ABA Antitrust Law Section Fall Forum Debate: Anticompetitive Conduct is Best Determined by the FTC
During the Fall Forum of the American Bar Association Antitrust Law Section, Partner Diane Hazel will moderate a debate that will argue the pros and cons of whether anticompetitive conduct is best determined by the FTC.